Shinichiro Nakajima

6.6k total citations
205 papers, 4.3k citations indexed

About

Shinichiro Nakajima is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Shinichiro Nakajima has authored 205 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Psychiatry and Mental health, 62 papers in Cognitive Neuroscience and 35 papers in Cellular and Molecular Neuroscience. Recurrent topics in Shinichiro Nakajima's work include Schizophrenia research and treatment (43 papers), Functional Brain Connectivity Studies (42 papers) and Dementia and Cognitive Impairment Research (23 papers). Shinichiro Nakajima is often cited by papers focused on Schizophrenia research and treatment (43 papers), Functional Brain Connectivity Studies (42 papers) and Dementia and Cognitive Impairment Research (23 papers). Shinichiro Nakajima collaborates with scholars based in Japan, Canada and United States. Shinichiro Nakajima's co-authors include Ariel Graff‐Guerrero, Masaru Mimura, Eric Plitman, Fernando Caravaggio, Philip Gerretsen, Yusuke Iwata, Yoshihiro Noda, Hiroyuki Uchida, Jun Ku Chung and Gary Remington and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Shinichiro Nakajima

191 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shinichiro Nakajima Japan 35 1.5k 1.1k 953 764 707 205 4.3k
Hiroaki Hori Japan 38 1.1k 0.7× 1.0k 1.0× 1.1k 1.1× 573 0.8× 667 0.9× 157 5.0k
Reiji Yoshimura Japan 36 1.4k 0.9× 969 0.9× 1.2k 1.3× 1.2k 1.6× 507 0.7× 276 4.8k
Serdar Dursun Canada 38 1.5k 1.0× 837 0.8× 995 1.0× 1.0k 1.4× 697 1.0× 139 4.8k
Yiru Fang China 42 1.6k 1.0× 1.1k 1.1× 1.3k 1.4× 643 0.8× 1.1k 1.5× 257 5.6k
James B. Lohr United States 50 2.6k 1.7× 1.3k 1.2× 790 0.8× 911 1.2× 870 1.2× 139 7.1k
Keming Gao United States 39 2.3k 1.6× 930 0.9× 600 0.6× 505 0.7× 598 0.8× 138 4.8k
Miho Ota Japan 38 1.1k 0.7× 1.0k 1.0× 1.1k 1.2× 737 1.0× 1.2k 1.7× 211 5.2k
Yuping Ning China 38 1.4k 0.9× 1.4k 1.3× 1.4k 1.4× 405 0.5× 671 0.9× 344 5.5k
Nunzio Pomara United States 30 1.1k 0.7× 697 0.7× 637 0.7× 582 0.8× 454 0.6× 131 3.5k
Robert A. McCutcheon United Kingdom 31 2.7k 1.8× 1.5k 1.4× 1.3k 1.4× 1.5k 1.9× 1.3k 1.8× 118 6.4k

Countries citing papers authored by Shinichiro Nakajima

Since Specialization
Citations

This map shows the geographic impact of Shinichiro Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinichiro Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinichiro Nakajima more than expected).

Fields of papers citing papers by Shinichiro Nakajima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinichiro Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinichiro Nakajima. The network helps show where Shinichiro Nakajima may publish in the future.

Co-authorship network of co-authors of Shinichiro Nakajima

This figure shows the co-authorship network connecting the top 25 collaborators of Shinichiro Nakajima. A scholar is included among the top collaborators of Shinichiro Nakajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinichiro Nakajima. Shinichiro Nakajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tani, Hideaki, Shiori Honda, Nobuhiro Nagai, et al.. (2025). Glutamate plus glutamine to GABA ratio as a predictor of ketamine response in treatment-resistant depression: A double-blind, randomized, open-label extension study. Journal of Affective Disorders. 383. 354–362.
2.
Kan, Hirohito, Shiori Honda, Masataka Wada, et al.. (2024). Alterations in subcortical magnetic susceptibility and disease-specific relationship with brain volume in major depressive disorder and schizophrenia. Translational Psychiatry. 14(1). 164–164. 4 indexed citations
3.
4.
Wada, Masataka, Shinichiro Nakajima, Shiori Honda, et al.. (2024). Decreased prefrontal glutamatergic function is associated with a reduced astrocyte-related gene expression in treatment-resistant depression. Translational Psychiatry. 14(1). 478–478. 3 indexed citations
5.
Tomasi, Dardo, Hideaki Tani, Shinichiro Nakajima, et al.. (2024). α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor density underlies intraregional and interregional functional centrality. Frontiers in Neural Circuits. 18. 1497897–1497897.
6.
7.
8.
So, Ryuhei, Yuji Yada, Masafumi Kodama, et al.. (2023). Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment‐resistant schizophrenia receiving clozapine: A 1‐year retrospective cohort study. Acta Psychiatrica Scandinavica. 148(5). 437–446. 3 indexed citations
9.
Tsugawa, Sakiko, Shiori Honda, Yoshihiro Noda, et al.. (2023). Associations Between Structural Covariance Network and Antipsychotic Treatment Response in Schizophrenia. Schizophrenia Bulletin. 50(2). 382–392. 5 indexed citations
10.
Sone, Daichi, Iman Beheshti, Shunichiro Shinagawa, et al.. (2022). Neuroimaging-derived brain age is associated with life satisfaction in cognitively unimpaired elderly: A community-based study. Translational Psychiatry. 12(1). 25–25. 16 indexed citations
11.
Iwata, Yusuke, Shinichiro Nakajima, Eric Plitman, et al.. (2021). Glutathione Levels and Glutathione-Glutamate Correlation in Patients With Treatment-Resistant Schizophrenia. Schizophrenia Bulletin Open. 2(1). sgab006–sgab006. 22 indexed citations
12.
Noda, Yoshihiro, Ryosuke Tarumi, Shiori Honda, et al.. (2020). White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 100. 109871–109871. 22 indexed citations
13.
Ogyu, Kamiyu, Yoshihiro Noda, Kazunari Yoshida, et al.. (2020). Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia. Neuropsychopharmacology Reports. 40(2). 138–149. 5 indexed citations
14.
Tarumi, Ryosuke, Yoshihiro Noda, Sakiko Tsugawa, et al.. (2020). Frontostriatal Structural Connectivity and Striatal Glutamatergic Levels in Treatment-Resistant Schizophrenia: An Integrative Analysis of DTI and 1H-MRS. Schizophrenia Bulletin Open. 1(1). 3 indexed citations
15.
Noda, Yoshihiro, Mera S. Barr, Fumi Masuda, et al.. (2019). Neural correlates of delay discount alterations in addiction and psychiatric disorders: A systematic review of magnetic resonance imaging studies. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 99. 109822–109822. 22 indexed citations
16.
Ueno, Fumihiko, Shinichiro Nakajima, Takefumi Suzuki, et al.. (2015). Whether to Increase or Maintain Dosage of Mirtazapine in Early Nonimprovers With Depression. The Journal of Clinical Psychiatry. 76(4). 434–439. 3 indexed citations
17.
Nakajima, Shinichiro, Hiroyuki Uchida, Robert R. Bies, et al.. (2015). Dopamine D2/3Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial. Schizophrenia Bulletin. 42(1). sbv106–sbv106. 18 indexed citations
18.
Uchida, Hiroyuki, Takefumi Suzuki, Koichiro Watanabe, et al.. (2011). The evolution of antipsychotic switch and polypharmacy in natural practice — A longitudinal perspective. Schizophrenia Research. 130(1-3). 40–46. 48 indexed citations
19.
Kawano, Kenji, et al.. (1994). Loss of Diltiazem Hydrochloride in Solutions in Polyvinyl Chloride Containers or Intravenous Administration Set. Hydrolysis and Sorption.. Japanese Journal of Hospital Pharmacy. 20(6). 537–541. 1 indexed citations
20.
Nakajima, Shinichiro, et al.. (1986). Loss of isosorbide dinitrate from solutions in administration set. (II) Comparison with nitroglycerin solutions.. Japanese Journal of Hospital Pharmacy. 12(4). 316–321. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroaki Hori Breakdown of academic impact, for papers by Reiji Yoshimura Breakdown of academic impact, for papers by Serdar Dursun Breakdown of academic impact, for papers by Yiru Fang Breakdown of academic impact, for papers by James B. Lohr Breakdown of academic impact, for papers by Keming Gao Breakdown of academic impact, for papers by Miho Ota Breakdown of academic impact, for papers by Yuping Ning Breakdown of academic impact, for papers by Nunzio Pomara Breakdown of academic impact, for papers by Robert A. McCutcheon
Rankless by CCL
2026